ResearchOur PeopleAllison Naleway

Allison L. Naleway, PhD

Meet Allison Naleway

Allison Naleway was interested in science from a young age, but it was a coincidental suggestion from a visiting professor that led her to choose a career in epidemiology. Her research portfolio includes studies of the flu vaccine, the HPV vaccine, and vaccination during pregnancy.

Allison Naleway, PhD, is a distinguished investigator whose research focuses on the evaluation of vaccine safety and effectiveness and on the surveillance of vaccine-preventable or other infectious diseases.

Dr. Naleway is an investigator with the Vaccine Safety Datalink, a national project of the Centers for Disease Control and Prevention (CDC) that links electronic medical record data from several integrated health care delivery organizations to monitor vaccine safety. Additionally, she has collaborated with the CDC on multiple studies to assess the effectiveness of COVID-19 and influenza vaccination in children, pregnant people, and health care personnel. She has also evaluated the effects of human papillomavirus vaccination on HPV-related outcomes, and has worked with medical and dental providers, patients, and families to improve the uptake of HPV and other vaccinations recommended for adolescents.

Dr. Naleway received her master’s and doctoral degrees in epidemiology from The University of Iowa’s College of Public Health and completed a postdoctoral fellowship in epidemiology at the Marshfield Clinic Research Foundation. She has an adjunct faculty appointment with The University of Iowa College of Public Health’s Department of Epidemiology. She joined CHR in 2003.

Selected Current Studies

  • Vaccine Safety Datalink-Infrastructure Activities—VSD (CDC)
  • Prospective Cohort Study of COVID-19 Vaccine Effectiveness in Children and Adults—CASCADIA: (CDC)
  • Virtual Influenza and COVID-19 Surveillance and Vaccines Effectiveness Network—VISION (CDC)

Selected Publications

  • Irving SA, Crane B, Weintraub E, Kauffman TL, Brooks N, Patel SA, Razzaghi H, Belongia EA, Daley MF, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Kharbanda E, Klein NP, Zerbo O, Naleway AL. Influenza Vaccination Among Pregnant People Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet Gynecol. 2023 Sep 1;142(3):636-639. doi: 10.1097/AOG.0000000000005285. Epub 2023 Aug 3. PMID: 37590982.
  • Naleway AL, Kim SS, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards LJ, Ball S, Grant L, Zunie T, Cao W, Gross FL, Groom H, Fry AM, Hunt D, Jeddy Z, Mishina M, Wesley MG, Spencer S, Thompson MG, Gaglani M, Dawood FS. Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020. Open Forum Infect Dis. 2023 Apr 21;10(6):ofad223. Doi: 10.1093/ofid/ofad223. PMID: 37305842; PMCID: PMC10249269.
  • Naleway AL, Henninger ML, Irving SA, Bianca Salas S, Kauffman TL, Crane B, Mittendorf KF, Harsh S, Elder C, Gee J. Epidemiology of Upper Limb Complex Regional Pain Syndrome in a Retrospective Cohort of Persons Aged 9-30 Years, 2002-2017. Perm J. 2023 Jun 15;27(2):75-86. doi: 10.7812/TPP/22.170. Epub 2023 May 8. PMID: 37154719; PMCID: PMC10266855.
  • Coronado GD, Petrik AF, Slaughter M, Kepka D, Naleway AL. Adolescents Who Have Undergone Human Papillomavirus Vaccination Are More Likely to Get a COVID-19 Vaccine. J Adolesc Health. 2023 Jun;72(6):985-988. doi: 10.1016/j.jadohealth.2022.12.022. Epub 2023 Feb 11. PMID: 36781325; PMCID: PMC9918864.
  • Naleway AL, Grant L, Caban-Martinez AJ, Wesley MG, Burgess JL, Groover K, Gaglani M, Yoon SK, Tyner HL, Meece J, Kuntz JL, Yoo YM, Schaefer-Solle N, Olsho LEW, Gerald JK, Rose S, Thiese MS, Lundgren J, Groom HC, Mak J, Louzado Feliciano P, Edwards LJ, Lutrick K, Dunnigan K, Phillips AL, Lamberte JM, Noriega R, Sokol BE, Odean M, Ellingson KD, Smith M, Hegmann KT, Respet K, Dickerson M, Cruz A, Fleary DE, Murthy K, Hunt A, Azziz-Baumgartner E, Gallimore-Wilson D, Harder JA, Odame-Bamfo L, Viergutz J, Arvay M, Jones JM, Mistry P, Thompson MG, Fowlkes AL. Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021. Influenza Other Respir Viruses. 2022 Jan 13. doi: 10.1111/irv.12956. Epub ahead of print. PMID: 35023288.
  • Naleway AL, Groom HC, Crawford PM, Salas SB, Henninger ML, Donald JL, Smith N, Thompson MG, Blanton LH, Bozio CH, Azziz-Baumgartner E. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 19;70(46):1608-1612. doi: 10.15585/mmwr.mm7046a4. PMID: 34793417; PMCID: PMC8601415.
  • Naleway AL, Crane B, Irving SA, Bachman D, Vesco KK, Daley MF, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Klein NP, McCarthy NL, McClure DL, Panagiotakopoulos L, Panozzo CA, Vazquez-Benitez G, Weintraub ES, Zerbo O, Kharbanda EO. Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. Ther Adv Drug Saf. 2021 Jun 14;12:20420986211021233. doi: 10.1177/20420986211021233. PMID: 34178302; PMCID: PMC8207278.
  • Naleway AL, Weinmann S, Krishnarajah S, Arondekar B, Fernandez J, Swamy G, Myers E. Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. PLOS One. 2015;10:e0117525.
  • Naleway AL, Weinmann S, Crane B, Gee J, Markowitz LE, Dunne EF. Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente Northwest. Sex Transm Dis. 2014;41:496-500.
  • Naleway AL, Irving SA, Henninger ML, Li D, Shifflett P, Ball S, Williams J, Cragan J, Gee J, Thompson MG. Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies. Vaccine. 2014;32:3122-7. Epub 2014 Apr 14.
  • Naleway AL, Henkle EM, Ball S, Bozeman S, Gaglani MJ, Kennedy ED, Thompson MG. Barriers and facilitators to influenza vaccination and vaccine coverage in a cohort of healthcare personnel. Am J Infect Control. 2014;42:371-5.
  • Naleway AL, Gold R, Drew L, Riedlinger K, Henninger ML, Gee J. Reported adverse events in young women following quadrivalent human papillomavirus vaccination. J Womens Health. 2012;21:425-35. Epub 2012 Jan 9.

Follow Us